SBT Pipeline |
Development Stage |
||||
|---|---|---|---|---|---|
| Therapeutic | Indication | Research | Preclinical | Phase 1 | Comments |
| SBT-100 (KRAS, P-STAT3) | Breast Cancer (TNBC, ER+/PR+, HER2+) |
|
2024 | Tested In Vitro and In Vivo | |
| Prostrate Cancer |
|
Tested In Vitro, In Vivo In Progress | |||
| Glioblastoma |
|
Tested In Vitro | |||
| Sarcoma |
|
2024 | Orphan Drug Status Granted by FDA | ||
| Pancreatic Cancer |
|
2024 | Orphan Drug Status Granted by FDA | ||